164 related articles for article (PubMed ID: 37256526)
1. Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
Moore-Palhares D; Chen H; Keith J; Wang M; Myrehaug S; Tseng CL; Detsky J; Perry J; Lim-Fat MJ; Heyn C; Maralani P; Lipsman N; Das S; Sahgal A; Soliman H
J Neurooncol; 2023 Jul; 163(3):541-551. PubMed ID: 37256526
[TBL] [Abstract][Full Text] [Related]
2. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R
Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810
[TBL] [Abstract][Full Text] [Related]
3. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.
Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G
Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134
[TBL] [Abstract][Full Text] [Related]
4. Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
Arvold ND; Shi DD; Aizer AA; Norden AD; Reardon DA; Lee EQ; Nayak L; Dunn IF; Golby AJ; Johnson MD; Claus EB; Chiocca EA; Ligon KL; Wen PY; Alexander BM
J Neurooncol; 2017 Dec; 135(3):581-591. PubMed ID: 28975467
[TBL] [Abstract][Full Text] [Related]
5. Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.
Gupta T; Maitre M; Gupta P; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Singh V; Chinnaswamy G; Epari S; Sahay A; Patil V; GodaSastri J
J Neurooncol; 2020 Apr; 147(2):405-415. PubMed ID: 32072441
[TBL] [Abstract][Full Text] [Related]
6. Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups.
Chun SJ; Park SH; Park CK; Kim JW; Kim TM; Choi SH; Lee ST; Kim IH
Radiother Oncol; 2018 Aug; 128(2):254-259. PubMed ID: 29937212
[TBL] [Abstract][Full Text] [Related]
7. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
[TBL] [Abstract][Full Text] [Related]
8. Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).
Navarria P; Minniti G; Clerici E; Tomatis S; Pinzi V; Ciammella P; Galaverni M; Amelio D; Scartoni D; Scoccianti S; Krengli M; Masini L; Draghini L; Maranzano E; Borzillo V; Muto P; Ferrarese F; Fariselli L; Livi L; Pasqualetti F; Fiorentino A; Alongi F; di Monale MB; Magrini S; Scorsetti M
J Neurooncol; 2019 Mar; 142(1):59-67. PubMed ID: 30515706
[TBL] [Abstract][Full Text] [Related]
9. Outcome of Second Line Treatment of Recurrent High- Grade Glioma by re-Irradiation or Bevacizumab-based Chemotherapy: A Cross Sectional Study.
Anvari K; Shahabadi M; Welsh JS; Javadinia SA; Zarei E
Asian Pac J Cancer Prev; 2023 May; 24(5):1507-1511. PubMed ID: 37247269
[TBL] [Abstract][Full Text] [Related]
10. Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors.
Lee J; Cho J; Chang JH; Suh CO
Yonsei Med J; 2016 Jul; 57(4):824-30. PubMed ID: 27189273
[TBL] [Abstract][Full Text] [Related]
11. A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas.
Dixit KS; Sachdev S; Amidei C; Kumthekar P; Kruser TJ; Gondi V; Grimm S; Lukas RV; Nicholas MK; Chmura SJ; Fought AJ; Mehta M; Raizer JJ
J Neurooncol; 2021 Dec; 155(3):297-306. PubMed ID: 34689306
[TBL] [Abstract][Full Text] [Related]
12. Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK).
Combs SE; Niyazi M; Adeberg S; Bougatf N; Kaul D; Fleischmann DF; Gruen A; Fokas E; Rödel CM; Eckert F; Paulsen F; Oehlke O; Grosu AL; Seidlitz A; Lattermann A; Krause M; Baumann M; Guberina M; Stuschke M; Budach V; Belka C; Debus J; Kessel KA
Cancer Med; 2018 May; 7(5):1742-1749. PubMed ID: 29573214
[TBL] [Abstract][Full Text] [Related]
13. Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system.
Krauze AV; Peters C; Cheng J; Ning H; Mackey M; Rowe L; Cooley-Zgela T; Smart DD; Camphausen K
Radiat Oncol; 2017 Nov; 12(1):191. PubMed ID: 29187219
[TBL] [Abstract][Full Text] [Related]
14. Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients.
Niyazi M; Jansen NL; Rottler M; Ganswindt U; Belka C
Radiat Oncol; 2014 Dec; 9():299. PubMed ID: 25529015
[TBL] [Abstract][Full Text] [Related]
15. Timing of re-irradiation in recurrent high-grade gliomas: a single institution study.
Zemlin A; Märtens B; Wiese B; Merten R; Steinmann D
J Neurooncol; 2018 Jul; 138(3):571-579. PubMed ID: 29520609
[TBL] [Abstract][Full Text] [Related]
16.
Fleischmann DF; Unterrainer M; Bartenstein P; Belka C; Albert NL; Niyazi M
J Neurooncol; 2017 Apr; 132(2):277-286. PubMed ID: 28102485
[TBL] [Abstract][Full Text] [Related]
17. Validation of an established prognostic score after re-irradiation of recurrent glioma.
Kessel KA; Hesse J; Straube C; Zimmer C; Schmidt-Graf F; Schlegel J; Meyer B; Combs SE
Acta Oncol; 2017 Mar; 56(3):422-426. PubMed ID: 28075197
[TBL] [Abstract][Full Text] [Related]
18. Initial results of a phase II trial of
Breen WG; Youland RS; Giri S; Jacobson SB; Pafundi DH; Brown PD; Hunt CH; Mahajan A; Ruff MW; Kizilbash SH; Uhm JH; Routman DM; Jones JE; Brinkmann DH; Laack NN
J Neurooncol; 2022 Jul; 158(3):323-330. PubMed ID: 35583721
[TBL] [Abstract][Full Text] [Related]
19. Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation.
Fleischmann DF; Unterrainer M; Corradini S; Rottler M; Förster S; la Fougère C; Siepmann T; Schwaiger M; Bartenstein P; Belka C; Albert NL; Niyazi M
PLoS One; 2019; 14(7):e0216111. PubMed ID: 31339892
[TBL] [Abstract][Full Text] [Related]
20. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.
Palmer JD; Siglin J; Yamoah K; Dan T; Champ CE; Bar-Ad V; Werner-Wasik M; Evans JJ; Kim L; Glass J; Farrell C; Andrews DW; Shi W
J Neurooncol; 2015 Sep; 124(2):215-21. PubMed ID: 26024653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]